Package Leaflet: Information for the Patient
CitraFleetOral Powder for Solution in Sachet
sodium picosulfate / light magnesium oxide / citric acid
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
5 Storage of CitraFleet
You are taking CitraFleet to clean your intestines (including the colon) before undergoing any diagnostic procedure that requires a clean intestine, for example a colonoscopy (a procedure that allows your doctor to look inside your intestine using a flexible and long instrument that your doctor inserts through your anus) or a radiological examination. CitraFleet is a powder that has a lemon flavor and aroma. It contains two types of laxatives mixed in each sachet that, when dissolved in water and ingested, empty and clean the intestines. It is essential to have an empty and clean intestine so that your doctor or surgeon can see it clearly.
CitraFleet is indicated in adults over 18 years old (including elderly people).
Do not take CitraFleet if you:
Warnings and precautions
Consult your doctor or pharmacist before starting to take CitraFleet if:
Keep in mind that after taking CitraFleet, you will have liquid stools. You should drink enough clear liquids (see section 3) to replace lost fluids and salts. If not, you may suffer from dehydration and low blood pressure, which can cause you to faint.
Taking CitraFleet with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
CitraFleet may affect or be affected by other medicines if you take them at the same time. If you are taking any of the medicines listed below, your doctor may decide to give you a different medicine or adjust the dose. Therefore, if you have not yet spoken to your doctor about these, consult them again to find out what to do regarding:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine.
Driving and using machines
Do not drive, operate tools, or use machines if you start to feel tired or dizzy after taking CitraFleet.
CitraFleet contains potassium and sodium
This medicine contains 5 mmol (or 195 mg) of potassium per sachet, which should be taken into account in patients with kidney failure or in patients with low-potassium diets.
This medicine contains less than 1 mmol of sodium (23 mg) per sachet; that is, it is essentially "sodium-free".
Follow the administration instructions of this medicine exactly as indicated by your doctor or pharmacist, as the hospital procedure may need to be repeated if you do not completely empty your intestines. In case of doubt, consult your doctor or pharmacist again.
Be prepared to expect liquid or soft and frequent stools at any time after taking a dose of CitraFleet.This is normal and shows that the medicine is working. It would be practical to make sure you have access to a bathroom until the effects have passed.
It is essential to follow a special diet (low in solids) the day before your procedure is scheduled. When you start taking the sachets of this medicine, you should not eat any solid food until you have finished your procedure. Always follow your doctor's dietary instructions.If you have any questions, contact your doctor or pharmacist.
Unless your doctor tells you to, you should not take more than the recommended dose in any 24-hour period.
Treatment plan
You should have been given two sachets of CitraFleet. Each sachet contains an adult dose.
Treatment can be administered in one of the following ways:
The time between the two sachets should be at least 5 hours.
Each sachet should be dissolved in a glass of water. Do not dilute the product by drinking water immediately after taking each sachet.
Wait about 10 minutes after taking each sachet, then drink, slowly, approximately 1.5 to 2 liters of clear liquids, at a rate of approximately 250 ml (small glass) to 400 ml (large glass) per hour. Broths and isotonic solutions are recommended to avoid dehydration. It is advised not to drink only water.
After taking the second sachet, drink 1.5-2 liters of liquids. Do not eat or drink anything at least 2 hours before the procedure, or as recommended by your doctor.
METHOD OF ADMINISTRATION:
Adults over 18 years old (including elderly people):
If you take more CitraFleet than you should, consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following are known side effects of CitraFleet and are listed according to their frequency:
Very common (may affect more than 1 in 10 people):
Abdominal pain.
Common (may affect up to 1 in 10 people):
Abdominal distension (swollen abdomen), thirst, anal discomfort, and proctalgia (anal pain), fatigue (tiredness), sleep disorders, headache, dry mouth, nausea (feeling like vomiting).
Uncommon (may affect up to 1 in 100 people)
Dizziness, vomiting, inability to control bowel movements (fecal incontinence).
Other side effects of unknown frequency(cannot be estimated from the available data)
Anaphylaxis or hypersensitivity, which are severe allergic reactions. You should go to the hospital immediately if you have any difficulty breathing, start to notice that your skin is reddening, or have any other symptoms that you think may be a manifestation of a severe allergic reaction.
Hyponatremia (low sodium levels in the blood), hypokalemia (low potassium levels in the blood), epilepsy, convulsions (seizures), orthostatic hypotension (low blood pressure when standing, which can make you feel dizzy or unsteady), confusion, skin rash, including urticaria, pruritus (itching), and purpura (bleeding under the skin).
Flatulence (gas) and pain.
This medicine is intended to allow you to have liquid or soft stools very regularly, similar to diarrhea. However, if after taking this medicine your stools become difficult or cause concern, you should talk to your doctor.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date stated on the sachet after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the empty packaging and any unused medicinal product in the SIGRE collection point at your pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicinal products. This will help protect the environment.
Composition of CitraFleet
Appearance and packaging of the product
CitraFleet is an oral powder for solution in sachet, which is supplied in packs of 2, 50, 50 (25x2), 100, 100 (50x2), 200, 200 (100x2), 500, 500 (250x2), or 1000 sachets containing a white crystalline powder. Each sachet contains an adult dose. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Casen Recordati, S.L.
Autovía de Logroño, Km 13,300
50180 Utebo - Zaragoza
Spain
You can request more information about this medicine by contacting the marketing authorization holder at the following email address:info@casenrecordati.com
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Citrafleet: Croatia, Denmark, Slovenia, Norway, Czech Republic.
CitraFleet: Germany, Austria, Belgium, Bulgaria, Cyprus, Slovakia, Spain, Estonia, Finland, France, Greece, Netherlands, Hungary, Ireland, Iceland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Poland, Portugal, United Kingdom (Northern Ireland), Romania, Sweden.
Date of the last revision of this leaflet:June 2023
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/